Advertisement

Parkinson’s disease among migrants in Europe: estimating the magnitude of an emerging phenomenon

  • Marco CanevelliEmail author
  • Giuseppe Bruno
  • Martina Valletta
  • Andrea Fabbrini
  • Nicola Vanacore
  • Alfredo Berardelli
  • Giovanni Fabbrini
Original Communication

Abstract

Introduction

The occurrence of age-related pathological conditions among subjects with a migration background and composing ethnic minorities is an emerging challenge for Western countries. Specifically, the onset of neurodegenerative diseases in these populations of individuals might assume special relevance and generate additional complexities for our healthcare systems. The aim of the present study was to estimate the number of Parkinson’s disease (PD) cases in migrant subjects living in Europe.

Methods

The estimated cases of PD among ≥ 50-year-old migrants living in Europe, and in each of the 32 considered countries, were calculated by multiplying the number of migrants (derived by the Eurostat data) with the age-specific prevalence rates of PD (obtained by a recent meta-analysis).

Results

Nearly 20 million migrants ≥ 50 years lived in Europe in 2017. The application of the age-specific prevalence rates led to the estimation of 129,645 overall PD cases in this population, accounting for the 8% of overall PD cases in Europe. National estimates widely ranged from 36 cases in Iceland to 29,390 cases in France.

Conclusion

The present findings suggest that the occurrence of PD in migrants and minority groups already constitutes an important issue for European healthcare systems and will assume further relevance given the rapidly evolving sociodemographic scenario. Characterizing the phenomenon at the “real world” level and implementing coordinated initiatives and strategies represent novel but pressing needs for our countries.

Keywords

Parkinson’s disease Migrants Epidemiology Public health Migrant health 

Notes

Compliance with ethical standards

Conflicts of interest

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. Authors have no conflicts of interest to disclose for the present study. Marco Canevelli is supported by a research grant of the Italian Ministry of Health (GR-2016-02364975) for the project “Dementia in immigrants and ethnic minorities living in Italy: clinical-epidemiological aspects and public health perspectives” (ImmiDem).

Ethical standards

The manuscript does not contain clinical studies or patient data.

References

  1. 1.
    Kristiansen M, Razum O, Tezcan-Güntekin H, Krasnik A (2016) Aging and health among migrants in a European perspective. Public Health Rev 37:20.  https://doi.org/10.1186/s40985-016-0036-1 CrossRefPubMedGoogle Scholar
  2. 2.
    Pringsheim T, Jette N, Frolkis A, Steeves TDL (2014) The prevalence of Parkinson’s disease: a systematic review and meta-analysis. Mov Disord 29:1583–1590.  https://doi.org/10.1002/mds.25945 CrossRefPubMedGoogle Scholar
  3. 3.
    Human Development Index (HDI) (2018) Human Development Reports, (n.d.). http://hdr.undp.org/en/content/human-development-index-hdi. Accessed 26 September 2018
  4. 4.
    Hemming JP, Gruber-Baldini AL, Anderson KE, Fishman PS, Reich SG, Weiner WJ, Shulman LM (2011) Racial and socioeconomic disparities in parkinsonism. Arch Neurol 68:498–503.  https://doi.org/10.1001/archneurol.2010.326 CrossRefPubMedGoogle Scholar
  5. 5.
    Dahodwala N, Siderowf A, Xie M, Noll E, Stern M, Mandell DS (2009) Racial differences in the diagnosis of Parkinson’s disease. Mov Disord 24:1200–1205.  https://doi.org/10.1002/mds.22557 CrossRefPubMedGoogle Scholar
  6. 6.
    Dahodwala N, Xie M, Noll E, Siderowf A, Mandell DS (2009) Treatment disparities in Parkinson’s disease. Ann Neurol 66:142–145.  https://doi.org/10.1002/ana.21774 CrossRefPubMedGoogle Scholar
  7. 7.
    Chan AK, McGovern RA, Brown LT, Sheehy JP, Zacharia BE, Mikell CB, Bruce SS, Ford B, McKhann GM (2014) Disparities in access to deep brain stimulation surgery for Parkinson disease: interaction between African American race and Medicaid use. JAMA Neurol 71:291–299.  https://doi.org/10.1001/jamaneurol.2013.5798 CrossRefPubMedGoogle Scholar
  8. 8.
    Schneider MG, Swearingen CJ, Shulman LM, Ye J, Baumgarten M, Tilley BC (2009) Minority enrollment in Parkinson’s disease clinical trials. Parkinsonism Relat Disord 15:258–262.  https://doi.org/10.1016/j.parkreldis.2008.06.005 CrossRefPubMedGoogle Scholar
  9. 9.
    Pan S, Stutzbach J, Reichwein S, Lee BK, Dahodwala N (2014) Knowledge and attitudes about Parkinson’s disease among a diverse group of older adults. J Cross Cult Gerontol 29:339–352.  https://doi.org/10.1007/s10823-014-9233-x CrossRefPubMedGoogle Scholar
  10. 10.
    Aldridge RW, Nellums LB, Bartlett S, Barr AL, Patel P, Burns R, Hargreaves S, Miranda JJ, Tollman S, Friedland JS, Abubakar I (2018) Global patterns of mortality in international migrants: a systematic review and meta-analysis. Lancet 392(10164):2553–2566.  https://doi.org/10.1016/S0140-6736(18)32781-8 CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  • Marco Canevelli
    • 1
    • 2
    Email author
  • Giuseppe Bruno
    • 1
  • Martina Valletta
    • 1
  • Andrea Fabbrini
    • 1
  • Nicola Vanacore
    • 2
  • Alfredo Berardelli
    • 1
    • 3
  • Giovanni Fabbrini
    • 1
    • 3
  1. 1.Department of Human NeuroscienceSapienza UniversityRomeItaly
  2. 2.National Center for Disease Prevention and Health PromotionNational Institute of HealthRomeItaly
  3. 3.IRCCS NEUROMEDPozzilliItaly

Personalised recommendations